‘‘(b) MEMBERSHIP.— 
‘‘(1) IN
GENERAL.—The Commission shall be 
composed of the following voting members: 
‘‘(A) The heads (or their designees) of the 
following Federal agencies and departments: 
‘‘(i) The Centers for Medicare & Med-
icaid Services. 
‘‘(ii) The Agency for Healthcare Re-
search and Quality. 
‘‘(iii) The Centers for Disease Control 
and Prevention. 
‘‘(iv) The Indian Health Service. 
‘‘(v) The Department of Veterans Af-
fairs. 
‘‘(vi) 
The 
National 
Institutes 
of 
Health. 
‘‘(vii) The Food and Drug Administra-
tion. 
‘‘(viii) The Health Resources and Serv-
ices Administration. 
‘‘(ix) The Department of Defense. 
‘‘(B) Twelve additional voting members ap-
pointed under paragraph (2). 
‘‘(C) Such additional voting members as 
may be appointed by the Secretary, at the Sec-
VerDate Sep 11 2014 
01:52 Nov 15, 2016
Jkt 069200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6203
E:\BILLS\H1192.RH
H1192
rfrederick on DSKBCBPHB2PROD with BILLS
retary’s discretion, from among the heads (or 
their designees) of governmental or nongovern-
mental entities that impact clinical care of indi-
viduals with any of the diseases and complica-
tions described in subsection (a). 
‘‘(2) ADDITIONAL
MEMBERS.—The Commission 
shall include additional voting members appointed by 
the Secretary, in consultation with national medical 
societies and patient advocacy organizations with ex-
pertise in the care and epidemiology of any of the dis-
eases and complications described in subsection (a), 
including one or more such members from each of the 
following categories: 
‘‘(A) Clinical endocrinologists. 
‘‘(B) Physician specialties (other than as 
described in subparagraph (A)) that play a role 
in diseases and complications described in sub-
section (a), such as cardiologists, nephrologists, 
and eye care professionals. 
‘‘(C) Primary care physicians. 
‘‘(D) Non-physician health care profes-
sionals, such as certified diabetes educators, reg-
istered dieticians and nutrition professionals, 
nurses, nurse practitioners, and physician assist-
ants. 
VerDate Sep 11 2014 
01:52 Nov 15, 2016
Jkt 069200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6203
E:\BILLS\H1192.RH
H1192
rfrederick on DSKBCBPHB2PROD with BILLS
‘‘(E) Patient advocates. 
‘‘(F) National experts in the duties listed 
under subsection (c). 
‘‘(G) Health care providers furnishing serv-
ices to a patient population that consists of a 
high percentage (as specified by the Secretary) of 
individuals who are enrolled in a State plan 
under title XIX of the Social Security Act or 
who are not covered under a health plan or 
health insurance coverage. 
‘‘(3) CHAIRPERSON.—The voting members of the 
Commission shall select a chairperson from the mem-
bers appointed under paragraph (2) from the category 
under paragraph (2)(A). 
‘‘(4) MEETINGS.—The Commission shall meet at 
least twice, and not more than 4 times, a year. 
‘‘(5) BOARD TERMS.—Members of the Commis-
sion appointed pursuant to subparagraph (B) or (C) 
of paragraph (1), including the chairperson, shall 
serve for a 3-year term. A vacancy on the Commis-
sion shall be filled in the same manner as the original 
appointments. 
‘‘(c) DUTIES.—The Commission shall— 
‘‘(1) evaluate programs of the Department of 
Health and Human Services regarding the utilization 
VerDate Sep 11 2014 
01:52 Nov 15, 2016
Jkt 069200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6203
E:\BILLS\H1192.RH
H1192
rfrederick on DSKBCBPHB2PROD with BILLS
of diabetes screening benefits, annual wellness visits, 
and other preventive health benefits that may reduce 
the incidence of the diseases and complications de-
scribed in subsection (a), including explaining prob-
lems regarding such utilization and related data col-
lection mechanisms; 
‘‘(2) identify current activities and critical gaps 
in Federal efforts to support clinicians in providing 
integrated, high-quality care to individuals with any 
of the diseases and complications described in sub-
section (a); 
‘‘(3) make recommendations regarding the co-
ordination of clinically-based activities that are being 
supported by the Federal Government with respect to 
the diseases and complications described in subsection 
(a); 
‘‘(4) make recommendations regarding the devel-
opment and coordination of federally funded clinical 
practice support tools for physicians and other health 
care professionals in caring for and managing the 
care of individuals with any of the diseases and com-
plications described in subsection (a), specifically 
with regard to implementation of new treatments and 
technologies; 
VerDate Sep 11 2014 
01:52 Nov 15, 2016
Jkt 069200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6203
E:\BILLS\H1192.RH
H1192
rfrederick on DSKBCBPHB2PROD with BILLS
‘‘(5) evaluate programs described in subsection 
(a) that are in existence as of the date of the enact-
ment of this section and determine if such programs 
are meeting the needs identified in paragraph (2) 
and, if such programs are determined as not meeting 
such needs, recommend programs that would be more 
appropriate; 
‘‘(6) recommend, with respect to the diseases and 
complications described in subsection (a), clinical 
pathways for new technologies and treatments, in-
cluding future data collection activities, that may be 
developed and then used to evaluate— 
‘‘(A) various care models and methods; and 
‘‘(B) the impact of such models and methods 
on quality of care as measured by appropriate 
care parameters (such as A1C, blood pressure, 
and cholesterol levels); 
‘‘(7) evaluate and expand education and aware-
ness activities provided to physicians and other health 
care professionals regarding clinical practices for the 
prevention of the diseases and complications described 
in subsection (a); 
‘‘(8) review and recommend appropriate methods 
for outreach and dissemination of educational re-
sources that— 
VerDate Sep 11 2014 
01:52 Nov 15, 2016
Jkt 069200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6203
E:\BILLS\H1192.RH
H1192
rfrederick on DSKBCBPHB2PROD with BILLS
‘‘(A) regard the diseases and complications 
described in subsection (a); 
‘‘(B) are funded by the Federal Government; 
and 
‘‘(C) are intended for health care profes-
sionals and the public; and 
‘‘(9) carry out other activities, such as activities 
relating to the areas of public health and nutrition, 
that the Commission deems appropriate with respect 
to the diseases and complications described in sub-
section (a). 
‘‘(d) OPERATING PLAN.— 
‘‘(1) INITIAL
PLAN.—Not later than 90 days 
after its first meeting, the Commission shall submit to 
the Secretary and the Congress an operating plan for 
carrying out the activities of the Commission as de-
scribed in subsection (c). Such operating plan may 
include— 
‘‘(A) a list of specific activities that the 
Commission plans to conduct for purposes of 
carrying out the duties described in each of the 
paragraphs in subsection (c); 
‘‘(B) a plan for completing the activities; 
‘‘(C) a list of members of the Commission 
and other individuals who are not members of 
VerDate Sep 11 2014 
01:52 Nov 15, 2016
Jkt 069200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6203
E:\BILLS\H1192.RH
H1192
rfrederick on DSKBCBPHB2PROD with BILLS
Congress a recommendation on whether the Commission 
should be reauthorized to operate after fiscal year 2019. 
‘‘(f) SUNSET.—The Commission shall terminate at the 
end of fiscal year 2019.’’. 
Amend the title so as to read: ‘‘A bill to amend the 
Public Health Service Act to foster more effective imple-
mentation and coordination of clinical care for people 
with a complex metabolic or autoimmune disease, a dis-
ease resulting from insulin deficiency or insulin resist-
ance, or complications caused by such a disease, and for 
other purposes.’’. 
VerDate Sep 11 2014 
01:52 Nov 15, 2016
Jkt 069200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H1192.RH
H1192
rfrederick on DSKBCBPHB2PROD with BILLS
Union Calendar No. 625 
114TH CONGRESS 
2D SESSION 
H. R. 1192 
[Report No. 114–801] 
A BILL 
To amend the Public Health Service Act to foster 
more effective implementation and coordination 
of clinical care for people with pre-diabetes, dia-
betes, and the chronic diseases and conditions 
that result from diabetes. 
NOVEMBER 14, 2016 
Reported with amendments, committed to the Committee 
of the Whole House on the State of the Union, and or-
dered to be printed 
VerDate Sep 11 2014 
01:52 Nov 15, 2016
Jkt 069200
PO 00000
Frm 00014
Fmt 6651
Sfmt 6651
E:\BILLS\H1192.RH
H1192
rfrederick on DSKBCBPHB2PROD with BILLS